BVF PARTNERS L P/IL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is a 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and a 10% Owner in AVIGEN INC \DE ($AVGN) and a 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and a 10% Owner in ARQULE INC ($ARQL) and a 10% Owner in CURIS INC ($CRIS) and a 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and a 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
Address: ONE SANSOME STREET, 31ST FLOOR SAN FRANCISCO 94104 CA
Companies in which BVF PARTNERS L P/IL is an Insider
ARQULE INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 12,244,073 shares
Current Value: $16,774,380
Latest Transaction: Nov 25 2008
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVIGEN INC \DE
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 8,310,015 shares
Latest Transaction: Nov 20 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CURIS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,951,716 shares
Current Value: $16,248,185
Latest Transaction: Apr 29 2009
$CRIS Market Capitalization: $368.24M
$CRIS Previous Close: $2.73
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYNAVAX TECHNOLOGIES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 8,110,657 shares
Current Value: $32,037,095
Latest Transaction: May 01 2009
$DVAX Market Capitalization: $154.11M
$DVAX Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EPIRUS Biopharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 10,008,871 shares
Latest Transaction: Dec 09 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 13,537,275 shares
Current Value: $1,459,859,736
Latest Transaction: Dec 09 2008
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROCRINE BIOSCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,946,547 shares
Current Value: $259,269,449
Latest Transaction: Jan 26 2009
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BVF PARTNERS L P/IL
Sentiment: All, ARQL, AVGN, CRIS, DVAX, CRXX, LGND, NBIX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 01 2009 | DVAX | DYNAVAX TECHNOLOGI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.30 | 13,000 | 16,900 | 8,110,657 | 8.1 M to 8.1 M (-0.16 %) |
| May 01 2009 | DVAX | DYNAVAX TECHNOLOGI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.30 | 4,000 | 5,200 | 8,123,657 | 8.1 M to 8.1 M (-0.05 %) |
| May 01 2009 | DVAX | DYNAVAX TECHNOLOGI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.30 | 5,000 | 6,500 | 8,127,657 | 8.1 M to 8.1 M (-0.06 %) |
| Apr 29 2009 | CRIS | CURIS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.15 | 1,741,000 | 2,002,150 | 5,951,716 | 7.7 M to 6 M (-22.63 %) |
| Apr 29 2009 | CRIS | CURIS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.15 | 502,000 | 577,300 | 7,692,716 | 8.2 M to 7.7 M (-6.13 %) |
| Apr 29 2009 | CRIS | CURIS INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 1.15 | 727,000 | 836,050 | 8,194,716 | 8.9 M to 8.2 M (-8.15 %) |
| Jan 26 2009 | NBIX | NEUROCRINE BIOSCIE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 6,000 | 18,586 | 5,946,547 | 5.9 M to 5.9 M (+0.10 %) |